Pragma Biosciences
San Carlos, US · Founded 2018 · Delaware corporation · 1 known investors
Gut microbiome mapping for better medicines
Founders & leadership
KB
Kareem BarghoutiNamed on SEC filing
AV
Ayin ValaNamed on SEC filing
PM
Peter McCaffreyNamed on SEC filing
KB
Kovi BessoffNamed on SEC filing
Board
NS
Nicholas ShekderdemianBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$14.5M disclosed across 1 round · 2022
▶$14.5MraisedSep 2022 · 22 investors · BiotechnologyRule 506(b)
▶$14.5MraisedSep 2022 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kareem BarghoutiExecutive Officer, Director
- Ayin ValaExecutive Officer, Director
- Nicholas ShekderdemianDirector
- Peter McCaffreyExecutive Officer, Director
- Kovi BessoffExecutive Officer
- Offering amount
- $20M
- Amount sold
- $14.5M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Pragma Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Pragma Biosciences do?
- Gut microbiome mapping for better medicines
- Who are Pragma Biosciences's investors?
- Pragma Biosciences's investors include The Venture Collective.
- How much funding has Pragma Biosciences raised?
- Pragma Biosciences has disclosed $14.5M raised across 1 round.
- Where is Pragma Biosciences headquartered?
- Pragma Biosciences is headquartered in San Carlos, US.